KYNB

Kyntra Bio Inc Cross-source read$7.97 0.06%
Health CareCUSIP 31572Q881· EOD Sep 11, 2026

Among active 13F managers last quarter, 1 opened and 1 added, while 2 reduced; the largest holder to move was Two Sigma Investments, LP (−19%). Over the last 180 days, 1 insider bought and none sold, a net +$20K in open-market trades.

Tracked 13F holders
29
6 in Q2 2026 filings
13F value (tracked)
$6.6M
Smart-money readMixed
Net sellingNet buying
Funds · active managers, latest 13F
2 adding · 2 trimming
Insiders · Form 4 open-market, 180d
1 buying · 0 selling · +$20K
US House · STOCK Act, 180d
0 buying · 0 selling

The legs disagree, or only one of them leans.

Price & smart-money activity

$7.97 0.06%5Y -97.2%
$4.75$173.42$342.10$510.77$679.4520212022202320242025202691932376224545
Hover for who · click for detailEnd-of-day closing prices52w $6.46 – $12.43

Who owns KYNB?

29 tracked 13F filers · ranked by shares held

29 tracked 13F filers disclose a position in KYNB as of the latest SEC 13F filings, a combined $6.6M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

#FundSharesPosition valueLast moveAs ofHistory
1Armistice Capital, LLC400K
$2.7M
Held
Q1 2026
2Vanguard Capital Management LLC160K
$1.2M
+2.1%
Added · +3K sh
Q2 2026
3BlackRock, Inc.84K
$637K
~0%
Reduced · −1 sh
Q2 2026
4Two Sigma Investments, LP50K
$336K
−19%
Reduced · −12K sh
Q1 2026
5Geode Capital Management, LLC43K
$326K
−6.0%
Reduced · −3K sh
Q2 2026
6HighTower Advisors, LLC40K
$269K
~0%
Reduced · −2 sh
Q1 2026
7UBS Group AG28K
$187K
+193%
Added · +18K sh
Q1 2026
8Renaissance Technologies LLC27K
$186K
−13%
Reduced · −4K sh
Q1 2026
9Vanguard Fiduciary Trust Co24K
$182K
+0.7%
Added · +163 sh
Q2 2026
10Birchview Capital, LP23K
$170K
Held
Q2 2026
11State Street Corp20K
$153K
Held
Q2 2026
12Jane Street Group, LLC12K
$83K
−2.1%
Reduced · −269 sh
Q1 2026
13ADAR1 Capital Management, LLC10K
$71K
Held
Q1 2026
14Group One Trading LLC4K
$33K
−1.9%
Reduced · −86 sh
Q2 2026
15Vanguard Global Advisers, LLC1K
$11K
Held
Q2 2026
16Axiom Investment Management LLC704
$5K
Held
Q2 2026
17Morgan Stanley488
$3K
−92%
Reduced · −5K sh
Q1 2026
18Tower Research Capital LLC (TRC)332
$2K
+54%
Added · +116 sh
Q1 2026
19Harbour Investments, Inc.200
$1K
New
+200 sh
Q1 2026
20National Bank Of Canada193
$1K
New
+193 sh
Q1 2026
21Osaic Holdings, Inc.180
$1K
+76%
Added · +78 sh
Q1 2026
22SBI Securities Co., Ltd.152
$1K
Held
Q2 2026
23Royal Bank Of Canada137
$1K
−0.7%
Reduced · −1 sh
Q1 2026
24BNP Paribas Financial Markets50
$339
+2.0%
Added · +1 sh
Q1 2026
25CWM, LLC26
$176
Held
Q1 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is KYNB being bought or sold by institutions?

Last quarter, 1 fund opened a new position in KYNB and 1 added to an existing one, while 2 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Opened
1
fund took a first position
Added
1
added to an existing position
Reduced
2
reduced, still holding
Biggest moves · ranked by size of the change, positions above a floor

Funds that own KYNB also own

CompanyCo-held byTheir position there
Bristol-Myers Squibb CoBMY9 funds$797.0M
Prothena Corp PLCPRTA9 funds$41.7M
Unitedhealth Group IncUNH8 funds$835.9M
Neurocrine Biosciences IncNBIX8 funds$822.7M
Nvidia CorpNVDA7 funds$3.0B
Micron Technology IncMU7 funds$1.7B
Alphabet Inc-CL AGOOGL7 funds$1.6B
Boston Scientific CorpBSX7 funds$796.4M
Intuitive Surgical IncISRG7 funds$749.0M
Microsoft CorpMSFT7 funds$748.8M
Morgan StanleyMS7 funds$738.4M
Regeneron PharmaceuticalsREGN7 funds$720.6M

Ranked by how many of KYNB's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in KYNB.

Insider activity (Form 4)

Full insider page →
Buys · 180d
$20K
1 insider
Net · 180d
$20K
1 open-market transaction
DateInsiderRoleActionSharesValue
May 14, 2026Wettig ThaneCEO, DirectorBuy (P)3K$20K
Nov 17, 2025Wettig ThaneCEO, DirectorBuy (P)3K$25K
Nov 13, 2025Wettig ThaneCEO, DirectorBuy (P)1K$9K
Jun 30, 2025Schoeneck James ADirectorBuy (P)24K$119K
Mar 24, 2025Wettig ThaneCEO, DirectorBuy (P)145K$51K
Mar 21, 2025Schoeneck James ADirectorBuy (P)50K$17K
Mar 20, 2025Schoeneck James ADirectorBuy (P)250K$88K
Jun 12, 2024Adib DeyaaChief Medical OfficerBuy (P)22K$26K
Mar 7, 2024Wettig ThaneCEOBuy (P)50K$96K
Sep 1, 2023Henderson Jeffrey WilliamDirectorSell (S)2K$2K
Aug 4, 2023Henderson Jeffrey WilliamDirectorSell (S)2K$4K
Jul 11, 2023Henderson Jeffrey WilliamDirectorSell (S)2K$5K

Do institutions, insiders and Congress agree?

Confluence: insiders and funds buying

Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.

SEC EDGAR 13F + Form 4 + US House STOCK Act{ }get_ticker_confluence · API & MCP

Signals by source

Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive

SourceBuyingSellingNet
13F funds
Top 100 holders by value, passive included; the hero counts active managers only
69
Insiders
Form 4 open-market
10+$20K
US House
STOCK Act trades
00$0
Sector rotation
KYNB is in Health Care, which smart money is rotating OUT OF
$5.0B

Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.

Institutional ownership over time

6 tracked filers in Q2 2026 filingsstill filing
01530Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
tracked filers holding their reported valueQ2 2026 filings so far: $656K
Each bar counts tracked filers with a position in that quarter's filings, so the newest bar excludes filers still on an earlier quarter. Arkolith's tracked universe has grown over this window; part of any long-run rise is coverage, not new buyers.

Recent filings

14 most recent

Keep exploring

Connected entities for KYNB

Browse more

Build

Ask your agent what changed in KYNB

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/KYNB/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for KYNB.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for KYNB. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.